Caring Through Connectivity: A cross-examination of the connected drug delivery device industry

European Pharmaceutical Manufacturer is a highly regarded publication covering the pharma/biopharma manufacturing supply chain from formulation to distribution, keeping readers informed of the latest news, opinions, developments and breakthroughs in this innovative and technologically advanced sector. The bi-monthly publication reaches over 18,000 readers, including decision makers and opinion leaders in the European pharma manufacturing industry.

In this article, we explore the global market for connected drug delivery devices. This market (injectables and inhalation devices specifically) is projected to reach $706 million by 2025 – that is to say a CAGR of over 25% from its $225 million value in 2020. This projected pace will however depend on a number of key stakeholders and their attitudes towards the development and adoption of these devices.

The potential efficiency benefits of connected drug delivery devices for healthcare systems are more apparent than ever and the growth of the connected device industry is inevitable but the extent of its large-scale deployment and the success of this will depend on the collaboration between parties.

Read more from our Head of Product Strategy and Insights, George I’ons.